微泰醫療-B(02235.HK)擬申請科創板上市
格隆匯11月16日丨微泰醫療-B(02235.HK)公吿,於2022年11月16日召開的董事會會議上,公司建議向中國相關監管機構申請配發及發行不多於93,460,000股A股,以及向上海證券交易所申請批准A股在科創板上市及買賣。
董事會認為,於科創版進行A股發行將使公司通過股權融資方式進入中國資本市場,改善其資本架構,並加速集團的業務發展進而增強其競爭力。再者,A股發行將使公司能夠取得在中國內地及香港股票市場的上市地位,因而進一步豐富其資本基礎及建立國內外融資平台。科創板自成立以來,吸引了許多技術實力非凡的企業。在科創板上市有利於公司進一步提升其品牌形象及在國內市場的影響力,促進公司及股東的整體價值及利益。作為一家雙重上市的公司,公司將需要同時遵守香港聯交所和上海證券交易所的上市規則,這將進一步優化公司的企業治理結構,為股東和潛在投資者提供更高的企業透明度,有利於保障股東的整體利益。
另外,由於公司維持快速增長勢頭,並持續向商業化階段邁進,除全球發售募集的所得款項外,A股發行可為公司提供額外資本,讓公司能夠進行必需的產能擴張以及推進在研管線產品的進一步研發及商業化。建議A股發行的募集資金將支持新一代產品的研發以及相關產品臨牀試驗和註冊階段的開支。就此而言,A股發行的募集資金用途應與全球發售的所得款項用途有明顯的區分。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.